Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03768440Phase 3Terminated
Phase 3, randomised trial (2 arms), sponsored by Boston Children's Hospital. Primary endpoint: Rescue Analgesic Consumption at 24 hours. Started Apr 2019; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03768440.